コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 timulating factor (G-CSF) and the ELR(+) CXC chemokine CXCL1.
2 inflammatory cytokines IL1beta, IL6, and the chemokine CXCL1.
3 opoietic tissue of the neutrophil-recruiting chemokine CXCL1.
4 t through seed-derived factors including the chemokine CXCL1.
5 on in response to both retinoic acid and the chemokine CXCL1.
6 ack of crossover reactivity with the related chemokine CXCL1.
7 and consequent secretion of pro-inflammatory chemokine, CXCL1.
8 bility through secreted products such as the chemokines CXCL1, 2, 3, and 8, through adhesion-dependen
9 ast, cathepsins specifically process ELR CXC chemokines CXCL1, -2, -3, -5, and -8 N-terminally to the
11 n-coupled receptor (GPCR) that binds the CXC chemokines, CXCL1-3 and CXCL5-8, and induces intracellul
12 lm infection led to significant increases in chemokine (CXCL1 and CCL2) and proinflammatory cytokine
14 ptor family, induced potent secretion of the chemokines CXCL1 and CCL2 as well as expression of induc
15 ated with marked astrocytic synthesis of the chemokines CXCL1 and CCL2 in response to both cytokine c
16 teria has higher levels of mRNA encoding the chemokines CXCL1 and CCL2 than does tissue isolated from
18 ed the secretion of VEGF and proinflammatory chemokines CXCL1 and CXCL16, leading to increased myeloi
19 ts demonstrated diminished production of the chemokines CXCL1 and CXCL2 and delayed neutrophil and T
21 eased mRNA expression of neutrophil-specific chemokines CXCL1 and CXCL2 in the lungs of C57BL/6 and I
22 peritonitis, we show in this study that the chemokines Cxcl1 and Cxcl2 play distinctive roles in enh
23 he melanoma growth and migration stimulatory chemokines CXCL1 and CXCL2 were significantly up-regulat
24 d T cells, whereas the neutrophil-attracting chemokines CXCL1 and CXCL2 were up-regulated in the CNS
25 -protein-coupled receptor CXCR2 (recognizing chemokines CXCL1 and CXCL2) as another arm feeding into
26 steoblasts constitutively expressed the ELR+ chemokines CXCL1 and CXCL2, and CXCL2 expression was ind
29 3 has been shown to have a high affinity for chemokines CXCL1 and CXCL8 and to diminish inflammation
32 lock the post-translational secretion of the chemokines CXCL1 and CXCL8 independent of transcription
33 ammatory cytokines and chemokines, including chemokines CXCL1 and CXCL8, which are both agonists of t
35 we found that expression of 2 PMN-attracting chemokines, Cxcl1 and Cxcl2, was rapidly and dramaticall
37 ogenous luminal restoration of IL-17-related chemokines, CXCL1 and CXCL5, improves host defenses agai
39 motactic chemokines KC (keratinocyte-derived chemokine) (CXCL1) and MIP-2 (macrophage inflammatory pr
40 es, TNF-alpha elicited marked release of the chemokine CXCL1, and the release was blocked by carbenox
41 hich revealed the neutrophil chemoattractant chemokine CXCL1 as one of the top genes upregulated.
43 nflammatory cytokines (sICAM-1 and IL-6) and chemokines (CXCL1, CCL1, CCL2 and CCL5) that are hallmar
44 ng showed many up-regulated genes, including chemokines (Cxcl1, Ccl7), cytokines (tumor necrosis fact
45 g infection, included upregulation of innate chemokines (Cxcl1, Cxcl10, and Cxcl16) that were also ex
46 TNF-alpha, IL1-b, IFN-gamma, and IL-12), and chemokines (CXCL1, CXCL2, CCL2, CCL3, CCL4, and CXCL10).
47 tory molecules (CD80, CD86, CD40, and CD70), chemokines (CXCL1, CXCL2, CXCL3, CCL12, CCL17), as well
49 6, IL-23, IL-1beta, as well as IL-17 and the chemokines CXCL1, CXCL2, and CCL2, whereas similarly tre
50 d endothelial expression of the neutrophilic chemokines CXCL1, CXCL2, and CXCL5 and led to a function
52 d deficit in their capability to release the chemokines CXCL1, CXCL2, CCL3, and CCL4 and TNF-alpha in
55 F], interleukin-17 [IL-17], and IL-1beta) or chemokine (CXCL1, CXCL5, CXCL9, and CXCL10) induction.
56 gories: proangiogenic factors (MMP9, VEGFA), chemokines (CXCL1, CXCL5, IL8, CCL2), cytokines (IL1B, I
57 ce proteins, CD80 and CD38, and cytokines or chemokines (CXCL1, CXCL5, RANTES) released by activated
60 differentially elicited a further downstream chemokine (CXCL1/CXCL8) autocrine loop, with the two loo
61 were expressed at adult levels, whereas the chemokines CXCL1, CXCL9, and CCL2 remained at baseline l
62 onuclear cells (PMNs) through binding of the chemokines CXCL1 (CXCR1) and CXCL8 (CXCR1 and CXCR2).
63 al colony forming units, and by elevation of chemokine CXCL1, cytokine IL-6, and endogenous G-CSF pro
64 okines, as well as a prolonged half-life for chemokine CXCL1-encoding mRNA after treatment with IL-17
65 instead reduced secretion of the angiogenic chemokine CXCL1 from head and neck cancer cells in vitro
66 s was governed by enhanced production of the chemokine CXCL1 from mast cells that localized at endoth
67 ncer Genome Atlas showed that the neutrophil chemokine CXCL1 gene was highly upregulated in colon tum
68 , HNP 1-3, elafin, and LL-37) and neutrophil chemokines (CXCL1/GRO-alpha, CXCL2/GRO-beta, CXCL5/ENA-7
69 and correspondingly had lower levels of the chemokine CXCL1 in bronchoalveolar lavage fluid and lung
73 previous studies have revealed that the CXC chemokine, CXCL1, is overexpressed in human malignant me
76 i) DC produced elevated levels of the murine chemokine CXCL1 (KC), interleukin 12p40, and RANTES in r
77 appin-2-treated PA01 up-regulated the murine chemokine CXCL1/KC after 2 hours with a corresponding in
78 cytes but with elevated levels of the ELR(+) chemokines (CXCL1/keratinocyte-derived chemokine and CXC
79 inflammatory cytokines (Il-6, Tnf-alpha) and chemokines (Cxcl1, Mcp-1, Mif-1alpha) and Nos2 in the in
83 ow here that IL-17 enhanced the stability of chemokine CXCL1 mRNA and other mRNAs through a pathway t
87 e data reveal a novel mechanism by which the chemokine CXCL1, through neutrophil recruitment, alters
88 r alpha (TNF-alpha), IL-10, and IL-6 and the chemokine CXCL1 were upregulated in cocultured HT-29 cel
89 and VCAM-1), and enhanced the release of CXC chemokine CXCL1 when incubated with primary cultures of
90 lso had higher levels of the proinflammatory chemokine CXCL1, which CD T cells produce, in the kidney
92 fungal immunity by driving production of the chemokine CXCL1, which recruited neutrophils expressing